Case Summary:     

At NAILG, we are proud to announce that our client, a medical scientist from Nepal, has successfully secured approval for his I-140 EB2-NIW (National Interest Waiver) petition, with the premium processing, despite receiving a Request for Evidence (RFE) during the process. After thoroughly reviewing his background and accomplishments in biomedical science, we recognized the national importance and potential of his work, making him a strong candidate for the petition. Our team carefully compiled and presented evidence of his research accomplishments, peer-reviewed publications, and recognition within the field to ensure a compelling case.

Client’s Strong Qualifications and National Impact.

As a medical scientist specializing in biomedical science, the client’s work addresses critical global health concerns, specifically therapeutic interventions for diabetes and liver diseases. His research is poised to significantly impact the understanding and treatment of these diseases, offering solutions to reduce healthcare costs and improve patient outcomes in the U.S.

With funding from prestigious institutions, a strong publication record, and citations reflecting the influence of his work, our client is well-positioned to continue advancing his endeavors. His ongoing contributions to the field promise to further benefit both public health and the medical community.

Key Accomplishments: Demonstrated Significant Recognition.

The petition highlighted several key accomplishments that underscored the client’s impact, including:

● A robust publication record, with 8 peer-reviewed journal articles (5 first-authored), 8 conference abstracts (4 first-authored), and 1 accepted book chapter.

● A total of 25 citations, demonstrating the influence of his research within the biomedical community.

● Peer review experience for prestigious journals, having completed 1 peer review, showcasing his recognition as an expert in his field.

● At least three of his papers rank among the most highly cited in Molecular Biology & Genetics for their respective years of publication.

● Research funding from esteemed institutions, including the National Eye Institute, the National Institute of General Medical Sciences, and the Congressionally Directed Medical Research Program of the Department of Defense.

Recommendation Letters Affirm His Contributions.

The petition included four recommendation letters, with two independent advisory opinions from highly regarded experts in the field. The following excerpt from these letters highlighted the innovative nature and national significance of the client’s research, further supporting the petition’s merit:

“[Client’s] leadership in biomedical science is clearly demonstrated by his evaluation of ER stress and its role in diabetic retinopathy. There is thus no doubt that [client] shall continue to produce additional valuable research, both driving progress in the field and bringing immense benefits to national and international concerns.”

Approval despite the RFE Challenge.

Our client received a Request for Evidence (RFE) during the review process. However, through NAILG’s thorough and well-documented response, we successfully addressed all concerns raised by USCIS, which ultimately led to the approval of his EB2-NIW petition.

NAILG’s Strategic Petition Preparation Leads to Approval.

USCIS approved the client’s EB2-NIW petition in just 5 months and 20 days, with the premium processing, a testament to the strength of his qualifications and the national importance of his work in biomedical science. NAILG’s thorough evaluation of the client’s qualifications and strategic petition preparation played a key role in securing the approval of the EB2-NIW petition, despite the RFE.

We congratulate our client on this outstanding achievement and are honored to have supported his continued contributions to advancing medical research and healthcare solutions in the United States.